Browsing by Author "Öven Ustaalioğlu, Bala Başak"
Now showing items 1-13 of 13
-
Capecitabine-cisplatin versus 5-fluorouracil/leucovorin in combination with radiotherapy for adjuvant therapy of lymph node positive locally advanced gastric cancer
Öven Ustaalioğlu, Bala Başak; Bilici, Ahmet; Tilki, Metin; Sürmelioğlu, Ali; Erkol, Burçak; Figen, Metin; Uyar, Serab (Wolters Kluwer Medknow Publications, 2018)Aim of the Study: Although surgery is considered to be curative treatment, recurrence rates are high in gastric cancer. Adjuvant 5-fluorouracil (5-FU) based chemoradiotherapy has been shown to improve the prognosis. We ... -
Clinical importance of discordance in hormone receptor and HER2/NEU status after neoadjuvant chemotherapy in breast cancer
Öven Ustaalioğlu, Bala Başak; Aker Vardar, Fügen; Bilici, Ahmet; Gürleyik, Günay; Erkol, Burçak; Kefeli, Umut (Elsevier, 2014)Aim: Neoadjuvant chemotherapy (NAC) is used longer for both locally advanced breast cancer and early stage to increase breast conservation. Discordance of the hormone receptor (HR) status was reported to be 8-33% of the ... -
Clinical importance of discordance of hormone receptors and Her2/neu status after neoadjuvant chemotherapy in breast cancer
Öven Ustaalioğlu, Bala Başak; Aker Vardar, Fügen; Bilici, Ahmet; Gürleyik, Günay; Erkol, Burçak; Kefeli, Umut; Aliustaoglu, Mehmet (Zerbinis Medical Publications, 2014)Purpose: The aim of this study was to compare the hormone receptors' (HR) and HER2/neu status between core needle biopsy (CNB) and residual tumor after surgery of breast cancer treated with neoadjuvant chemotherapy (NAC), ... -
Clinical role of 18F-FDG-PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: is there any effect of FDG-PET/CT in patients' management?
Bilici, Ahmet Erkan; Şeker, Mesut; Öven Ustaalioğlu, Bala Başak; Aslan Canpolat, Nesrin; Tekinsoy, Bülent; Salepçi, Taflan; Gümüş, Mahmut (Oxford University Press, 2010)... -
Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?
Bilici, Ahmet Erkan; Öven Ustaalioğlu, Bala Başak; Şeker, Mesut; Aslan Canpolat, Nesrin; Tekinsoy, Bülent; Salepçi, Taflan; Gümüş, Mahmut (Springer, 2010)The aim of this study was to evaluate the clinical value of FDG PET/CT in patients with suspected ovarian cancer recurrence as compared with diagnostic CT, and to assess the impact of the results of FDG PET/CT on treatment ... -
The clinicopathologic characteristics and prognostic factors of gastroesophageal junction tumors according to Siewert classification
Öven Ustaalioğlu, Bala Başak; Tilki, Metin; Sümelioğlu, Ali; Bilici, Ahmet; Gönen, Can; Ustaalioğlu, Recep; Balvan, Özlem; Aliustaoğlu, Mehmet (AVES, 2017)Objective: The treatment of gastroesophageal junction tumors remains controversial due to confusion on whether they should be considered as primary esophageal or as gastric tumors. The incidence of these tumors with poor ... -
The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival
Öven Ustaalioğlu, Bala Başak; Balvan, Özlem; Bilici, Ahmet Erkan; Develi, Ahmet Çağrı; Aliustaoǧlu, Mehmet; Vardar, Fugen; Erkol, Burçak (Springer-Verlag, 2015)In the literature, small number of study has addressed time of recurrence in breast cancer. We analyzed clinicopathological factors predicting early or late recurrence in breast cancer patients and also prognostic factors ... -
Important factors affecting adjuvant treatment decision in stage IA breast cancer patients in Turkey
Öven Ustaalioğlu, Bala Başak; Bilici, Ahmet; Erkol Yılmaz, Burçak; Aliustaoğlu, Mehmet; Şeker, Mesut; Vardar, Fügen; Gümüş, Mahmut (S. Karger AG, 2014)Introduction: In Turkey, the gene expression profile test is not standard, so adjuvant treatment is planned according to clinicopathological factors. Therefore, we retrospectively analyzed important parameters that affect ... -
Modified docetaxel and cisplatin in combination with capecitabine (DCX) as a first-line treatment in HER2- negative advanced gastric cancer
Bilici, Ahmet; Selçukbiricik, Fatih; Demir, Nazan; Öven Ustaalioğlu, Bala Başak; Dikilitaş, Mustafa; Yıldız, Özcan (Asian Pacific Organization for Cancer Prevention, 2014)Background: Docetaxel and cisplatin in combination with fluorouracil (DCF) regimen is accepted to be one of the standard regimens in the treatment of advanced gastric cancer. However, substantial toxicity has limited its ... -
Modified docetaxel and cisplatin in combination with capecitabine (DCX) as first-tine treatment in HER2-negative advanced gastric cancer
Bilici, Ahmet; Selçukbiricik, Fatih; Demir, Nazan; Öven Ustaalioğlu, Bala Başak; Dikillitaş, Mustafa; Yıldız, Özcan (American Society of Clinical Oncology, 2014)… -
Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors
Gümüş, Mahmut; Bilici, Ahmet; Odabaş, Hatice; Öven Ustaalioğlu, Bala Başak; Kandemir, Nurten; Demirci, Umut; Cihan, Şener; Bayoğlu, İbrahim Vedat; Öztürk, Türkan; Türkmen, Esma; Urakçı, Zürat; Şeker, Mehmet Metin; Günaydın, Yusuf; Selçukbiricik, Fatih; Turan, Nedim; Sevinç, Alper (Springer, 2017)Background Currently, it is accepted that risk assessment of clinical stage I (CS I) nonseminomatous germ cell tumors (NSGCT) patient is mainly dependent on the presence of lymphovascular invasion (LVI). Initial active ... -
The prognostic factors for operated gallbladder cancer
Öven Ustaalioğlu, Bala Başak; Bilici, Ahmet; Şeker, Mesut; Kefeli, Umut; Dinçer, Aydın (Oxford University Press, 2017)Introduction: Surgery is the only curative treatment for localized gallbladder cancer. The prognosis is poor because low rate of patients can be found eligible for potential curative surgery. Lymph node metastasis is known ... -
The role of F-18-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?
Bilici, Ahmet; Öven Ustaalioğlu, Bala Başak; Şeker, Mesut; Kefeli, Umut; Canpolat, Nesrin; Tekinsoy, Bülent; Özuğur, Şule; Gümüş, Mahmut (Springer, 2011)F-18-fluorodeoxyglucose (FDG) PET/CT has been widely used for staging, re-staging and for monitoring therapy-induced changes and response to therapy in patients with various types of cancer, but its utilization for gastric ...
